Vasopressor medications are used to increase blood pressure in hypotensive, intensive
care unit (ICU) patients. Typically, vasopressors are administered as continuous intravenous
(IV) infusions. Due to the quick onset and short half-life of vasopressor medications,
these infusions are able to be quickly titrated to a target blood pressure. However,
the administration of continuous infusions can be delayed because of the time required
to compound and deliver the medications. Recent evidence even suggests that infusion
dead space can delay medication administration by several minutes [
[1]
]. Greater duration of hypotension has been associated with increased risk of mortality,
acute kidney injury, and myocardial injury in adult ICU patients [
[2]
].To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effect of intravenous infusion dead space on time to drug delivery in infants.Baylor Univ Med Cent Proc. 2018; 31 (Apr 3): 168-170
- The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients.Intensive Care Med. 2018; 44 (Jun 1): 857-867
- Hemodynamic monitoring in the operating room.Resuscitation. 1984; 11: 165-173
- VI Medical intelligence article New York state guidelines on the topical use of phenylephrine in the operating room.New York. 2000; : 859-864
- Cardiopulmonary compromise after use of topical and submucosal α-agonists: possible added complication by the use of β-blocker therapy.Otolaryngol - Head Neck Surg. 1997; 117: 56-61
- A case of cardiac arrest after topical phenylephrine administration in adenoidectomy surgery.Int J Pediatr. 2015; 3: 81-84
- Safety of bolus-dose phenylephrine for hypotensive emergency department patients.Am J Emerg Med. 2018; 36: 1802-1806
- The impact of push-dose phenylephrine use on subsequent preload expansion in the ED setting.Am J Emerg Med. 2016; 34: 2419-2422
- Push dose pressors: experience in critically ill patients outside of the operating room.Am J Emerg Med. 2018; 37: 494-498
- A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther. 1981; 30: 239-245
- Asking the correct questions of push dose vasopressors.Am J Emerg Med. 2019; 37: 1599
- Safety of peripheral intravenous administration of vasoactive medication.J Hosp Med. 2015; 10: 581-585
- Safety of phenylephrine infusion through peripheral intravenous catheter in the neurological intensive care unit.J Intensive Care Med. 2018; 33: 589-592
- Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis.Crit Care Med. 1982; 10: 432-435
- Effect of phenylephrine on the haemodynamic state and cerebral oxygen saturation during anaesthesia in the upright position.Br J Anaesth. 2013; 111: 229-234
- The systemic and regional hemodynamic effects of phenylephrine in sheep under normal conditions and during early hyperdynamic sepsis.Anesth Analg. 2012; 115 (Aug): 330-342
- The accuracy and variability of bolus injections with different sized syringes.Can J Anaesth. 1992; 39: 198-201
Article Info
Publication History
Published online: May 27, 2020
Accepted:
May 24,
2020
Received in revised form:
May 3,
2020
Received:
March 3,
2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
